Retinoids for Cutaneous SCC and Verrucal Keratosis in Patients on BRAF Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Systemic Retinoids for the Chemoprevention of Cutaneous Squamous Cell Carcinoma and Verrucal Keratosis in a Cohort of Patients on BRAF Inhibitors
Br J Dermatol 2013 Dec 01;169(6)1310-1313, R Anforth, TC Blumetti, A Clements, R Kefford, GV Long, P Fernandez-PeñasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.